This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Nalivela Kumara Swamy: Innovator in Pyrimidine Compounds
Introduction
Nalivela Kumara Swamy is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrimidine compounds. His research focuses on developing new methods and compositions for treating various diseases.
Latest Patents
Nalivela Kumara Swamy holds a patent for "Pyrimidine compounds, process for their preparation and compositions containing them." This invention is directed towards compounds, methods, and compositions for making these compounds. It addresses the treatment of a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, and dyslipidemia. The invention emphasizes the administration of new heterocyclic compounds, particularly substituted pyrimidines, represented by a general formula.
Career Highlights
He is currently associated with Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company. His work at Dr. Reddy's has allowed him to contribute to the development of innovative therapeutic solutions. With a focus on research and development, he has been instrumental in advancing the company's mission to provide affordable and accessible healthcare.
Collaborations
Nalivela Kumara Swamy has collaborated with notable colleagues, including Ish Khanna and Manojit Pal. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Nalivela Kumara Swamy's contributions to the field of medicinal chemistry, particularly through his patent on pyrimidine compounds, highlight his role as an innovator. His work continues to impact the treatment of various diseases, showcasing the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
